Drug intelligence / Profile preview

bupivacaine + dexamethasone sodium phosphate

Development stage
Approved
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Infiltration, Perineural, Epidural
01

Overview

This is a combination drug consisting of bupivacaine, an amide-type local anesthetic, and dexamethasone sodium phosphate, a synthetic glucocorticoid corticosteroid. Bupivacaine acts by blocking voltage-gated sodium channels in neuronal membranes, thereby inhibiting nerve impulse conduction and producing local or regional anesthesia or analgesia. Dexamethasone sodium phosphate provides potent anti-inflammatory effects by modulating immune responses and suppressing inflammation through glucocorticoid receptor activation. When used together (often as an admixture for injection), dexamethasone serves as an adjuvant to prolong the duration of analgesia provided by bupivacaine in various regional anesthesia techniques such as peripheral nerve blocks and epidural blocks[1][2][8]. The combination is primarily indicated for surgical anesthesia/analgesia where prolonged pain control is desired.

Brand names
MARDEX 25 KITMARDEX25 KITMARDEX-25 KIT
Other names
bupivacaine hydrochloride + dexamethasone sodium phosphatebupivacaine + dexamethasone
02

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on bupivacaine + dexamethasone sodium phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + dexamethasone sodium phosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call